Meeting
2023 ASCO Annual Meeting
Variation in FOLFOX, FOLFIRI, and FOLFOXIRI effects on CD8+ T cell and PDL1 levels in MSS CRC patients.
Authors
Lindsey Carlsen
Brown University, Providence, RI
Lindsey Carlsen , Andrew Elliott , Marzia Capelletti , Emil Lou , John Marshall , Heinz-Josef Lenz , Philip A. Philip , Michael J. Hall , George W. Sledge Jr., Alexander G Raufi , Rimini Breakstone , Khaldoun Almhanna , Benedito A. Carneiro , Howard Safran , Wafik S. El-Deiry
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3526)
DOI
10.1200/JCO.2023.41.16_suppl.3526
Abstract #
3526
Poster Bd #
226
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comprehensive characterization of PTPRT expression in colorectal cancer (CRC).
First Author: Francesca Battaglin
First Author: Sandra Algaze
Poster
2022 ASCO Annual Meeting
Characterization of NY-ESO-1 gene expression in gastric cancer (GC).
First Author: Annika Lenz
First Author: Tin-Yun Tang